Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.
Ambrosis N, Martin Aispuro P, Belhart K, Bottero D, Crisp RL, Dansey MV, Gabrielli M, Filevich O, Genoud V, Giordano A, Lin MC, Lodeiro A, Marceca F, Pregi N, Lenicov FR, Rocha-Viegas L, Rudi E, Solovey G, Zurita E, Pecci A, Etchenique R, Hozbor D. Ambrosis N, et al. Among authors: martin aispuro p. Front Med (Lausanne). 2021 Feb 4;8:640688. doi: 10.3389/fmed.2021.640688. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33614689 Free PMC article.
Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.
Gaillard ME, Bottero D, Zurita ME, Carriquiriborde F, Martin Aispuro P, Bartel E, Sabater-Martínez D, Bravo MS, Castuma C, Hozbor DF. Gaillard ME, et al. Among authors: martin aispuro p. Front Immunol. 2017 Sep 6;8:1099. doi: 10.3389/fimmu.2017.01099. eCollection 2017. Front Immunol. 2017. PMID: 28932228 Free PMC article.
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Rudi E, et al. Among authors: martin aispuro p. Front Immunol. 2022 Sep 29;13:1020159. doi: 10.3389/fimmu.2022.1020159. eCollection 2022. Front Immunol. 2022. PMID: 36248791 Free PMC article.
Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.
Bottero D, Rudi E, Martin Aispuro P, Zurita E, Gaillard E, Gonzalez Lopez Ledesma MM, Malito J, Stuible M, Ambrosis N, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Bottero D, et al. Among authors: martin aispuro p. Front Immunol. 2023 Nov 10;14:1271209. doi: 10.3389/fimmu.2023.1271209. eCollection 2023. Front Immunol. 2023. PMID: 38022542 Free PMC article.